abstract |
The present invention relates to certain novel pyrazine derivatives (formula I) as SHP2 inhibitors represented by the formula (I), their synthesis, and their use for treating SHP2-mediated disorders: [Formula I] . More particularly, the present invention relates to fused heterocyclic group derivatives useful as SHP2 inhibitors, to methods of making such compounds and to methods of treating SHP2-mediated disorders. |